Biogen (NASDAQ: BIIB) shares have dipped more than 1% premarket on the back of news that the company and Eisai ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE